Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Revue Medicale De Liege|December 14, 2023
[Finerenone (Kerendia®), a new weapon against the chronic kidney disease of a patient with type 2 diabetes]André Scheen, Pierre DelanayeDiabetes Care|May 23, 2015
Weight management in type 2 diabetes: current and emerging approaches to treatmentLuc Van Gaal, André ScheenVascular Health and Risk Management|March 1, 2007
Insulin detemir in the treatment of type 1 and type 2 diabetesJean-Christophe Philips, André ScheenRevue Medicale De Liege|April 11, 2024
[First-line treatment of hypercholesterolemia : start with statin monotherapy or ezetimibe-statin combination ?]André Scheen, Caroline Wallemacq, Patrizio LancellottiRevue Medicale De Liege|October 13, 2023
[Evolocumab (Repatha®) : new therapy ofhypercholesterolaemia for secondary prevention of atherosclerotic disease]André Scheen, Caroline Wallemacq, Patrizio LancellottiRevue Medicale De Liege|October 14, 2024
[New outcome studies with injectable semaglutide in different at risk populations]André Scheen, Pierre Delanaye, Patrizio LancellottiRevue Medicale De Liege|April 11, 2024
[Patient with type 2 diabetes and coronary heart disease developing heart failure]André Scheen, Nicolas Paquot, Patrizio LancellottiRevue Medicale De Liege|June 23, 2023
[Reactive hypoglycaemia, a frequently mentioned functional disorder, yet overestimated in clinical practice]André Scheen, Nicolas Paquot, Pierre LefèbvreRevue Medicale De Liege|March 16, 2023
[Anti-obesity drugs : from previous disappointments to new hopes]André Scheen, Jenny De Flines, Nicolas PaquotRevue Medicale De Liege|November 15, 2024
[Finerenone and cardiorenal protection : from controlled clinical trials to real-life clinical practice]Jean-Christophe Philips, Régis Radermecker, André ScheenPageof 9